Alibaba Health Information Technology Limited (HKG:0241)

HKG:0241 Balance Sheet

Financials in millions CNY. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	5,434	2,218	3,490	10,917	10,548
Short-Term Investments	4,431	5,618	6,063	-	-
Trading Asset Securities	300.41	263.62	-	-	-
Cash & Short-Term Investments	10,165	8,100	9,553	10,917	10,548
Cash Growth	25.50%	-15.21%	-12.50%	3.50%	-9.36%
Accounts Receivable	1,266	1,053	785.14	578.79	515.99
Other Receivables	1,182	1,021	1,126	700.56	557.95
Receivables	2,448	2,073	1,911	1,279	1,074
Inventory	1,849	1,415	1,400	2,102	1,550
Prepaid Expenses	641.58	384.49	370.03	464.7	330.45
Restricted Cash	318.79	303.24	278.41	150.26	63.13
Total Current Assets	15,422	12,276	13,512	14,914	13,566
Property, Plant & Equipment	87.62	69.72	103.67	68.55	165.11
Long-Term Investments	6,364	7,602	4,900	4,591	4,297
Goodwill	805.34	810.85	810.85	810.85	810.85
Other Intangible Assets	258.23	275.22	292.07	309.01	326.22
Long-Term Deferred Tax Assets	20.73	50.82	54.87	34.1	17.39
Other Long-Term Assets	134.77	93.48	31.57	20.02	20.29
Total Assets	23,093	21,178	19,705	20,748	19,202

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	3,030	2,852	3,351	3,714	3,529
Accrued Expenses	268.3	215.08	92.71	176.06	169.82
Current Portion of Leases	29.58	10.58	34.19	37.44	50.66
Current Income Taxes Payable	121.87	136.21	88.87	63.4	40.83
Current Unearned Revenue	852.48	695.1	554.68	495.07	260.68
Other Current Liabilities	791.28	832.83	904.43	951.43	771.56
Total Current Liabilities	5,093	4,742	5,025	5,437	4,822
Long-Term Leases	30.18	24.94	47.98	40.36	84.76
Long-Term Deferred Tax Liabilities	113.09	98.15	114.3	122.82	116.48
Other Long-Term Liabilities	-	-	-	-	106.36
Total Liabilities	5,237	4,865	5,188	5,601	5,130

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	143.55	142.79	142.78	119.13	119.1
Additional Paid-In Capital	51,687	51,516	51,375	43,734	43,500
Retained Earnings	3,149	1,324	-11.97	-841.83	-1,309
Treasury Stock	-8.53	-52.6	-101.95	-70.48	-23.52
Comprehensive Income & Other	-37,115	-36,619	-36,859	-27,767	-28,188
Total Common Equity	17,855	16,312	14,544	15,174	14,098
Minority Interest	1.16	0.98	-26.61	-26.37	-26.19
Shareholders' Equity	17,857	16,313	14,518	15,147	14,072
Total Liabilities & Equity	23,093	21,178	19,705	20,748	19,202

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	59.76	35.52	82.17	77.8	135.41
Net Cash (Debt)	10,106	8,064	9,471	10,839	10,412
Net Cash Growth	25.31%	-14.85%	-12.63%	4.10%	-10.23%
Net Cash Per Share	0.62	0.50	0.67	0.80	0.77
Filing Date Shares Outstanding	16,100	16,076	14,575	13,497	13,487
Total Common Shares Outstanding	16,100	16,076	14,575	13,497	13,487
Working Capital	10,329	7,534	8,487	9,476	8,743
Book Value Per Share	1.11	1.01	1.00	1.12	1.05
Tangible Book Value	16,792	15,226	13,441	14,054	12,961
Tangible Book Value Per Share	1.04	0.95	0.92	1.04	0.96
Machinery	45.18	86.43	81.91	71.45	74.8
Leasehold Improvements	24.04	23.73	24.88	25.09	25.34

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 30, 2026

Data Sources Report a data error